Kadcyla, a drug that can offer some women with advanced breast cancer nearly six months of extra life, which was trialled here in the North East, has for now been rejected for use in the NHS, because of its high cost.
A Newcastle doctor whose patients have been involved in the clinical trials is disappointed by the decision.
Dr Mark Verrill, from the Freeman Hospital, say the drug is revolutionary.
More top news
Kerrie Gosney brings you Sunday night's forecast
Rain moving through on Sunday evening, but Monday looks like one of the better days of the week ahead
The stakes are high for the Labour leader, writes Chris Ship - will another general election be on the cards in the coming months?